1 / 68

Breast Cancer Screening

Breast Cancer Screening. Margaret Thompson MD Breast Surgeon Cleveland Clinic Florida. Screening Recommendations. PREVIOUS Guidelines for Early Detection of Breast Cancer in Average-Risk, Asymptomatic Women. Age 20-39 Clinical breast examination at least every 3 years

andersonc
Download Presentation

Breast Cancer Screening

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Breast Cancer Screening Margaret Thompson MD Breast Surgeon Cleveland Clinic Florida

  2. Screening Recommendations

  3. PREVIOUSGuidelines for Early Detection of Breast Cancer in Average-Risk, Asymptomatic Women • Age 20-39 • Clinical breast examination at least every 3 years • Breast self-examination • Age 40 and over • Annual mammogram • Annual clinical breast examination • Monthly Breast self-examination

  4. October 20, 2015

  5. Breast Self-Examination

  6. Evaluating Breast Complaints & Masses

  7. Screening Mammogram • Only imaging modality proven to reduce breast cancer mortality • 20-year follow-up before & after introduction of screening • Age 40-69, 44% reduction in breast cancer mortality Tabar, Lancet 2003

  8. Diagnostic Studies • Diagnostic Mammogram • Targeted Breast Ultrasound • Breast MRI • Percutaneous CNB • USG CNB • SCNB • MRIG CNB

  9. Screening vs Diagnostic Mammogram Screening Mammogram • No breast s/s • Goal is to find breast cancer when it’s too small to be palpated • Usually takes 2 views of each breast. • Some women, such as those with large breasts, may need to have more pictures to see as much breast tissue as possible.

  10. Screening vs Diagnostic Mammogram • Diagnostic mammograms • Investigate possible problems • Lump, nipple discharge, pain, skin changes • Abnormal screening mammogram • Images reviewed by radiologist at same time •  Can be spot, rolled, magnification views • Better define calcifications, overlapping glandular tissue vs underlying lesion

  11. Tomosynthesis (TOMO)=3D mammogram

  12. Tomosynthesis (TOMO) = 3D Mammogram • Uses X-ray like the standard 2-D digital mammography • Tomo camera moves in an arc over the breast • Taking 15 mini-pictures within 4 seconds • These multiple pictures create layer-by-layer look of breast tissue, 1mm at a time • Thus, removing tissue overlap that may hide cancers or mistake dense breast tissue as tumors

  13. Tomosynthesis (TOMO)=3D mammogram • Why is TOMO a better? • Less need for recalls • Fewer false-positives • Fewer invasive testing procedures • Earlier detection / treatment • Compression similar to or slightly less pressure than a standard 2-D

  14. BIRADS Classification

  15. Biopsy • 1 in 6 women Will Need A Breast Biopsy • Millions Performed Each Year • 80% Non Cancerous (5-7% High risk) • ↑ performed for Non-Palpable Lesions

  16. Minimally Invasive Biopsy Techniques • Accurately dx malignant or pre-malignant breast lesions • Avoid an open surgical procedure for benign abnormalities • Allows additional breast imaging prior to initial therapy • Maintains patient eligibility for NACT trials • Fertility, plastic surgical, & genetic consultations can be obtained before definitive surgical excision • Optimizes oncologic & cosmetic surgical planning • Goal is to minimize # of surgical interventions • Surgery can more often be performed as a single procedure with clear margins • Resulting in fewer financial & nonfinancial burdens to the patient

  17. Fine Needle Aspiration • FNA of Solid Masses • 25 – 28 gauge • Yields Cytological Information, Not Histological • Insufficient Data For Diagnosis In Up 36% Of Cases For Nonpalpable Lesions

  18. Core Needle Biopsy

  19. Vacuum Assist – CNB • Same General Principle As CNB, 7-11 gauge • Vacuum Used To Pull Tissue Into Sampling Chamber • Removed With High-Speed Internal Rotating Knives • Specimen Suctioned Into Chamber • Multiple Samples Removed Through Single-Insertion

  20. Hand Held Vs Vacuum Asst

  21. USG, SCNB, MRI Guided? • Depends on the target lesion • mass vsmicrocalcifications • Target location • mid-depth breast vs adjacent to skin or implant vs axilla • Intent to remove the entire lesion • Training & experience of person doing the biopsy

  22. Stereotactic Core Needle Biopsy • Microcalcifications – • Indeterminate / Suspicious • Non-palpable Mammographic Solid Lesions • Asymmetric Densities • Lesion Seen In Only One View • Lesions Seen Only On Mammogram

  23. Stereotactic Core Needle Biopsy

  24. Ultrasound Guided CNB

  25. MRI Guided CNB

  26. Post Biopsy Mammogram Calcs Post biopsy clip

  27. Open Surgical Biopsy • Increases • Repeated Surgery • Costs • Time to complete treatment

  28. Wire / Needle Localization Breast Biopsy • Nonpalpable Lesions • Cannot Be Seen By Intraoperative US • Preoperative Wire Placement in Radiology • Painful • Anxiety • Delay to OR

  29. I-125 Radioactive Seed Localization (RSL) • SEED vs WIRE localization • Significant benefit of RSL • Involved margin status • Re-operation rates • Reduced operative time • No stat sig diff • Volume of tissue excised

  30. I-125 Radioactive Seed Localization (RSL)

  31. Punch Biopsy • Inserted into center of skin lesion • Twist / turn with slight pressure, small plug of tissue removed

  32. Management of Specific Benign Breast Complaints

  33. Mastalgia • Most common breast complaint • Cyclical or noncyclical, idiopathic • Resolves spontaneously 20-30% • Recur 60% • R/t caffeine intake, PMS, hormone levels • Most respond to reassurance

  34. Fibrocystic Changes • AKA Fibrocystic disease • Premenopausal, 30-50 yo • Lumpy bumpy on p/e • Treat symptoms / reassurance • FNA • Cytology if bloody aspirate • Clip placement • Not collapse  CNB

  35. Management Mastalgia & Fibrocystic Changes • Avoid or ↓ Caffeine • Coffee, Tea, Sodas, Chocolates, Red Bull • Avoid or ↓ Nicotine • ↓ Salt Intake • Support / Sports Bra • Avoid Underwire Bra • Ibuprofen / NSAIDs • Warm Compresses / Heating Pad • Evening of Primrose Oil • Vitamin E

  36. Nipple Discharge • Usually due benign condition • Physiologic d/c • Ductalectasia • Intraductalpapilloma • Characteristics • Self induced  counsel to stop • Spontaneous • Uni or bilateral • Uni or multiductal • Color - Milky, bloody, clear, darker green-brown • Posttraumatic, cyclical

  37. Ductal Ectasia

  38. Bloody Nipple Discharge • IntraductalPapilloma • Most common cause • 17% malignancy • Mammo, US, MRI, ductogram • Excision • Single duct excision • +/- Localization • Major duct excision

  39. Fibroepithelial LesionsFibroadenomas • Most common benign breast lesion; 20-30 yo • Usual stable or slow growth • c/o solitary nontender mass • p/e smooth rubbery mobile mass • US, +/-mammogram, +/- CNB • Tx: monitor, close f/u q 6 m, surgical excision, cryoablation

  40. Fibroepithelial LesionsPhyllodes Tumor • Similar to FAs • Rapid growth, larger sizes • Need CNB • Difficult to differentiate from FAs • Pathological dx on CNB needs surgical excision to r/o PT • Low, intermediate, high grade • Minimal metastatic potential, proclivity for LR, need 1 cm margin on excision

More Related